Biotech · Private company
Provention Bio, a Sanofi Company
Track this companyFree. Adds Provention Bio, a Sanofi Company to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- PRV-015Phase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PRV-3279Phase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- teplizumab 1 mg/mLPhase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- TeplizumabDiabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- PRV-3279-2a Trial in Systemic LupusPHASE2 · TERMINATED · started Jan 20, 2022ClinicalTrials.gov NCT05087628 · fetched Nov 12, 2026
- Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)ACTIVE_NOT_RECRUITING · started Oct 26, 2020ClinicalTrials.gov NCT04598893 · fetched Nov 12, 2026
- PRV-015 in Gluten-free Diet Non-responsive Celiac DiseasePHASE2 · COMPLETED · started Aug 24, 2020ClinicalTrials.gov NCT04424927 · fetched Nov 12, 2026
- At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)PHASE2 · COMPLETED · started Feb 26, 2020ClinicalTrials.gov NCT04270942 · fetched Nov 12, 2026